MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-AP-06-0009708
Dinakara Life Sciences Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹7.8 Cr
▼ 66% YoY
Net loss · FY 2025
₹4.64 Cr
Net margin -59.4%
EBITDA · FY 2025
-₹4.41 Cr
EBITDA margin -56.5%
Authorised capital
₹8.05 Cr
Registered with MCA
Paid-up capital
₹6 Cr
Issued & subscribed
Open charges
₹9 Cr
Satisfied ₹16.65 Cr
Company age
9 yrs
Est. 2017
Employees · EPFO
22
Provident fund records
About Dinakara Life Sciences Private Limited
Data last updated:
Dinakara Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 01 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2017PTC115562. Its GSTIN is 37AAGCD0500R1ZK (Andhra Pradesh).
The company has an authorised share capital of ₹8.05 Cr and a paid-up capital of ₹6 Cr. It is led by directors Mahesh Venkata Ranga Narsinha Pidimarri and Kavita Pidimarri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.8 Cr, a decline of 66% compared to the previous year. For the same year it recorded a net loss of ₹4.64 Cr (net margin -59.4%) and EBITDA of -₹4.41 Cr (EBITDA margin -56.5%). Revenue has declined at a compounded annual rate (CAGR) of 35% over three years and 19% over five years.
The company has about 22 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹9 Cr and satisfied charges of ₹16.65 Cr on record. Court records list 8 cases involving the company, including 2 filed by the company and 6 filed against it; 1 case is pending. The company has 1 deal on record (1 secondary share transfer); the latest was in June 2018. Its 7 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Issar Pharmaceuticals Private Limited with revenue of ₹8.31 Cr.
Dinakara Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-06-0009708). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dinakaralifesciences.com.
Company details
CIN U24100TG2017PTC115562
Registration Number 115562
Incorporation Date 01 March 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-AP-06-0009708
Recognitions & Rankings of Dinakara Life Sciences
Contact details
Dinakara Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its website is dinakaralifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUnit No.706 Manjeera Trinity Corporate, Kphb Phase 3, Hyderabad, Telangana, India – 500072
- IndustryPharma, API Manufacturers
To see the full contact details of Dinakara Life Sciences Private Limited, buy the company report.
Comprehensive company report
Dinakara Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Dinakara Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Dinakara Life Sciences Private Limited, buy the company report.
Financials of Dinakara Life Sciences Private Limited
FY 2025 filings availableDinakara Life Sciences Private Limited reported revenue of ₹7.8 Cr (down 66% YoY) for FY 2025.
Revenue · FY 2025
₹7.8 Cr ▼ 66%
Net loss · FY 2025
₹4.64 Cr margin -59.4%
EBITDA · FY 2025
-₹4.41 Cr margin -56.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 66%
3 years · compounded
▼ 35%
5 years · compounded
▼ 19%
EBITDA CAGR growth
3 years · compounded
▼ 62%
5 years · compounded
▼ 32%
Revenue has declined at a compounded annual rate (CAGR) of 19% over five years, including a 66% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.41 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.64 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -56.5% | ||||
| Net Profit Margin | -59.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dinakara Life Sciences Private Limited, buy the company report.
Board of directors of Dinakara Life Sciences Private Limited
Dinakara Life Sciences has 2 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahesh Venkata Ranga Narsinha Pidimarri | Director | 11 Jan 2024 | 2 Years 9 Months | Current |
| Kavita Pidimarri | Director | 11 Jan 2024 | 2 Years 9 Months | Current |
Peer comparison
Dinakara Life Sciences Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Issar Pharmaceuticals Private Limited | ₹8.31 Cr (FY 2024) | Hyderabad, Telangana, India | ||||
| RVR Labs Private Limited | ₹8.24 Cr (FY 2023) | 72.0% | Hyderabad, Telangana, India | |||
| Harihar Pharma Chem Private Limited | ₹8.13 Cr (FY 2025) | -59.0% | Ankleshwar, Gujarat, India | |||
| Bo-Chem Private Limited | ₹7.82 Cr (FY 2024) | 149.0% | Mumbai, Maharashtra, India | |||
| Dinakara Life Sciences Private Limitedthis company | ₹7.8 Cr (FY 2025) | -₹4.64 Cr | -59.4% | -66.0% | 22 | Hyderabad, Telangana, India |
| SNJ Lifecare Private Limited | ₹7.7 Cr (FY 2025) | -6.0% | Rajkot, Gujarat, India | |||
| Pharmacopius Drugs Private Limited | ₹7.6 Cr (FY 2024) | 8.0% | Kottayam, Kerala, India | |||
| Suraj Laboratories Private Limited | ₹7.54 Cr (FY 2025) | 1830.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Dinakara Life Sciences Private Limited, buy the company report.
Auditor
Dinakara Life Sciences Private Limited is audited by PADARTHI VENKATESH & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PADARTHI VENKATESH & CO | FY 2024 | 020949S |
Shareholding
The shareholding of Dinakara Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Dinakara Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹9 Cr
Satisfied charges
₹16.65 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Mar 2025 | 101082053 | Others | ₹9 Cr | Open | |
| 23 May 2024 | 100931711 | Others | ₹9 Cr | Satisfied | |
| 22 Mar 2018 | 100183194 | Others | ₹7.65 Cr | Satisfied |
To see the full charge records of Dinakara Life Sciences Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Dinakara Life Sciences Private Limited has 1 deal on record (1 secondary share transfer); the latest was in June 2018.
Total deals
1
Secondary share transfer
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2018 | Secondary share transfer | Undisclosed | Buyer: Endoc Lifecare Private Limited Seller: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Dinakara Life Sciences Private Limited has 8 court cases on record: 2 filed by Dinakara Life Sciences, 6 filed against it. 1 case is pending and 7 are disposed.
Total cases
8
Filed by the company
2
Filed against the company
6
Pending
1
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 6 | 1 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, DAKSHINA KANNADA, Karnataka | Court case (Ex.C) | Filed against the company by M/S Shriram City Union Finance Ltd | Disposed |
| District court, UDUPI, Karnataka | Criminal complaint | Filed by the company against Managing Director Agrigold Pvt. Constructions Ltd. and 1 other | Pending |
| District court, DAKSHINA KANNADA, Karnataka | Criminal complaint | Filed against the company by The South Canara District Central Co.Op Bank Ltd. Mangaluru | Disposed |
| District court, DAKSHINA KANNADA, Karnataka | Criminal complaint | Filed against the company by The South Canara District Central Co-Operative Bank Ltd.,Shirthady Branch,Rep by Smt Veena Nayak | Disposed |
| District court, DAKSHINA KANNADA, Karnataka | Criminal complaint | Filed against the company by The South Canara District Central Co Operative Bank Ltd, Rep by Its Manager, Veena Nayak. | Disposed |
To see the full case history of Dinakara Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Dinakara Life Sciences Private Limited was last rated by Crisil on 17 Oct 2019.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 17 Oct 2019 |
To see the full credit ratings and regulatory alerts of Dinakara Life Sciences Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dinakara Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Dinakara Life Sciences Private Limited has a workforce of 22 employees on its EPFO records as of Sep 23, 2025, across 1 active EPFO establishment.
Employee count
22
Active EPFO establishments
1
Employee growth
-8.33%
GST
Dinakara Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAGCD0500R1ZK | Andhra Pradesh | Active | 24 Jul 2017 |
To see the full GST registrations and return filing status of Dinakara Life Sciences Private Limited, buy the company report.
Recent activity
Dinakara Life Sciences Private Limited has 12 board changes on record since 2024: 2 appointments and 10 cessations. The latest: Kavita Pidimarri ceased to be Additional Director on 21 Apr 2024.
AGM
Dinakara Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Dinakara Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge registered on 23 May 2024 via Charge ID 100931711 with Others was fully satisfied on 28 Mar 2025.
Charges
A charge with Others amounted to Rs. 9.00 Cr with Charge ID 101082053 was registered on 24 Mar 2025.
Charges
A charge with Others amounted to Rs. 9.00 Cr with Charge ID 100931711 was registered on 23 May 2024.
Ceased
Kavita Pidimarri ceased to be Additional Director.
Ceased
Mahesh Venkata Ranga Narsinha Pidimarri ceased to be Additional Director.
Ceased
Laljibhai Dayabhai Barsia ceased to be Nominee Director.
Ceased
Nageswara Rao Donepudi ceased to be Director.
Ceased
Radha Krishna Neravena ceased to be Director.
Ceased
Ramanjaneyulusetty Devisetty ceased to be Director.
Ceased
Sachidanandamurthy Narla ceased to be Director.
9 earlier events are in the company report.
Frequently asked questions
Dinakara Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 01 March 2017 (9+ years old) and is registered under CIN U24100TG2017PTC115562.
Dinakara Life Sciences has 2 current directors:
- Mahesh Venkata Ranga Narsinha Pidimarri - Director
- Kavita Pidimarri - Director
The latest financial statements of Dinakara Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Dinakara Life Sciences is 37AAGCD0500R1ZK, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Dinakara Life Sciences is U24100TG2017PTC115562. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dinakara Life Sciences has 8 court cases on record: 2 filed by the company and 6 filed against it. 1 is pending.
Dinakara Life Sciences was incorporated on 01 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
Dinakara Life Sciences has 1 deal on record (1 secondary share transfer); the latest was in June 2018.
The peers of Dinakara Life Sciences by revenue are Issar Pharmaceuticals Private Limited, RVR Labs Private Limited, Harihar Pharma Chem Private Limited, Bo-Chem Private Limited, SNJ Lifecare Private Limited and 2 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kavita Pidimarri ceased to be Additional Director on 21 Apr 2024. Mahesh Venkata Ranga Narsinha Pidimarri ceased to be Additional Director on 21 Apr 2024. Laljibhai Dayabhai Barsia ceased to be Nominee Director on 15 Apr 2024. Dinakara Life Sciences has 12 board changes on record in total.
Yes, Dinakara Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-AP-06-0009708).